FDA Lull In Rx Promotion Citations Continues; Guidances May Be Bigger Priority
Even with recent letters, Office of Prescription Drug Promotion’s slow pace continues from 2014’s record low.
You may also be interested in...
House 21st Century Cures discussion draft would adjust FDA promotion regulations for Twitter, requiring that information communicated through hyperlink be considered part of the original post.
Agency originally said it would issue a draft guidance on industry’s interactions with formulary committees in 2014, but CDER Director Woodcock says “extremely contentious” issues have slowed progress.
Agency cites firm for unapproved claim, not including any risk information, and not submitting link to FDA.